| INTRODUCTION
The use of Pencil Beam Scanning (PBS) is expanding rapidly in proton therapy, in large part because the approach produces highly conformal dose distributions and facilitates optimized delivery, without the requirement of field-specific hardware such as compensators or apertures, in contrast to conventional double scattering and uniform scanning delivery. At the University of Pennsylvania Roberts Proton Therapy Center, PBS delivery has been implemented for clinical treatment on two universal nozzles and one dedicated nozzle.
MC-based dose calculation is generally superior to analytical algorithms commonly used in treatment planning system (TPS) in modeling the dose distribution for PBS treatments. [1] [2] [3] This is particularly true when protons propagate through bone-soft tissue, soft tissue-air, and bone-air interfaces in treatment sites such as head and neck and lung, as multiple Coulomb scattering (MCS) can lead to a distortion of the field and inadequate target coverage. 2, 3 While PBS eliminates most patient specific hardware, a beam modifier is still required in some situations. Various technical constraints in the current delivery systems result in a minimum proton energy limitation of between 70 and 100 MeV, 4 thus a range shifter is needed to degrade the proton range in order to treat tumors located shallower than the minimum range. 5 It is well known that the energy spread (due to energy straggling) and spot size (due to MCS)
increase at the exit of a range shifter. 6 To minimize the spot broadening, the air gap between the range shifter and patient should be as small as possible, though the potential for collision with the patient often requires a gap that is larger than physically optimal. Due to the generation of secondary products as well as the particle transport within the air gap, it is difficult to model the dose calculation with a range shifter analytically given a limited measured data set, 5 thus an approach such as MC is desirable; the broader MC generated dataset is valuable for analytically approximating the low-dose halo 5 using multi-Gaussian lookup tables in water or in air after a range shifter given the magnification of potential MCS and halo calculation inaccuracies by various range shifter thicknesses and air gaps. 7, 8 For any MC dose calculation, the first step is always to construct an accurate source model to parameterize the proton's distribution information in phase space (beam size, angular divergence and energy spread) at the position where it enters the simulated area. Several 12 as is a double-Gaussian fluence model, 8 to avoid dose inaccuracies. Hence, the range shifter in this paper is included as part of the simulated area as described by Grevillot 10 rather than creating an additional source model. The methodology is subsequently validated using a comprehensive set of measurements in water, both without and with range shifter to emphasize role of the low-dose halo, and also an anthropomorphic lung phantom for dose accuracy in heterogeneous medium. 
| MATERIALS AND METHODS

2.A | Source model
The design of the dedicated PBS nozzle (IBA Particle Therapy, Louvain-la-Neuve, Belgium; model: Dedicated Pencil Beam Nozzle) used in this study has been described by Farr 4 and Lin. 23 A schematic view of the nozzle system is presented in Fig. 1 . In this section, we describe how the source model parameters are determined based on a set of reference measurements.
2.A.1 | Modeling the beam optics
The model uses the IEC61217 gantry coordinate system, where the source plane is on the positive z-axis and the origin is at isocenter.
The source plane is set at the upstream surface of the range shifter to ensure that the range shifter can be correctly calculated when used in treatment (Fig. 1) . A parameterization of the source model at the source plane is therefore required, including the spatial beam spread distribution (beam spot size), σ x , and the angular spread distribution (beam divergence), σ xθ , as well as the coefficient of correlation ρ x (the same relation holds for the y-direction). According to Courant-Snyder's particle transportation theory, 24 the σ-matrix of a beam's parameters at any location Z along the beam path, neglecting dissipation and diffusion processes, can be described as
from which we infer that the variance of the spot size along the beam path should satisfy
Spot profiles at six locations in air along the Z-axis (455, 330, 200, 100, 0, and −100 mm) were acquired using a scintillation screen/CCD camera detector (Lynx ® -IBA Dosimetry, Schwarzenbruck, Germany) with a 0.5-mm resolution 25 for proton energies from 100 to 220 in 10-MeV steps plus 115 and 225 MeV. Corresponding parameters at isocenter σ x ð0Þ; ρ x ð0Þ and σ xθ ð0Þ were HUANG ET AL.
| 559 derived by fitting the spot size to location Z with Eq. (2). The spot size at any Z plane, such as the source plane, can be calculated using Eq. (2), while coefficient of correlation can be calculated from
which is positive for a defocusing beam and negative for a focusing beam. Although σ θ increases slightly with propagation in air due to MCS, we approximate it as a constant in air between the nozzle exit and the phantom surface. The beam optic parameters above are derived to reproduce the measured spot variance in air which has taken into account the slightly increased divergence due to the scattering effect of air. The space between source plane and the simulated object, therefore, is set to vacuum in the MC simulation.
In contrast to the parallel scanning PBS system at PSI, 4 
2.A.2 | Modeling the beam energy spectrum
A Gaussian distribution, with a sigma defined in terms of a percentage of the mean energy value, tuned to reproduce the measured depth-dose distribution in water, was applied to the energy spectrum. 10, 26 The relative integral Bragg peak curves were collected in a water phantom for protons entering the center of a Bragg peak chamber (Model 34070, PTW, Freiburg, Germany) with a diameter of 81.6 mm, for proton energies from 100 to 220 MeV in 10 MeV steps plus 115 and 225 MeV. The conversion of measured range to an initial mean energy was performed using the NIST PSTAR database, 27 as described in Grevillot et al. 28 The geometry of the scoring stack in the MC simulations was set to have the same diameter as the Bragg Peak chamber and a thickness resolution of 0.5 mm. With the beam optic properties and initial mean energy derived previously, different energy spreads with 0.05 MeV resolution were simulated to determine the optimal choice by evaluating the dose-to-peak ratio and mean point-to-point dose for each nominal energy 10, 26 ; the mean energy was further tuned to achieve a good range agreement with measurement. Relative dose comparison between simulated and measured depth-dose profiles normalized to the integral dose deposited was performed.
2.A.3 | Modeling protons per MU
The reference dosimetry approach proposed by Gomà et al. 29 was used to determine protons per MU; 1 MU corresponds to 3 nC collected in a 10 mm gap air-filled ionization chamber on the IBA proton therapy systems. The absolute dose was measured using a monoener- 
where D Meas is the dose measured by ionization chamber. Fracchiolla et al. 26 have reported that the difference in protons per MU between this approach and that using a Faraday cup is 0.5% on average. 
2.A.4 | Modeling the range shifter
In the range shifter modeling approach of Fracchiolla et al. number of measurements for the Bragg peak curves and spot profiles. The interaction of the protons with the range shifter generates additional secondary particles resulting in a larger halo; propagation through the air gap between range shifter and patient will create significant difficulties for both experiment and simulation. 5 To address these challenges, we simulate the range shifter as an object within the beam path as described by Grevillot, 10 specifying its geometry dimension, material composition, mass density, and mean excitation energy. The dedicated nozzle has a 65-mm thick Lexan range shifter with water equivalent thickness 74.1 mm (modeled with elemental compositions of carbon 75.575%, oxygen 18.876% and hydrogen 5.549%; mass density 1.20 g/cm 3 and mean excitation energy of 73.1 eV from the NIST PSTAR database 27 ) installed at the end of nozzle exit. Rather than a detailed single-spot profile validation of the halo, 7,12,30-32 field size factors (FSF) for square fields with 4 mm spacing and 1 MU per spot of monoenergetic proton beams, described by Pedroni et al., 4 Sawakuchi et al., 33 Zhu et al., 34 and
2.B | Model validation measurements
Shen et al, 35 were used to investigate the accuracy of the halo both with and without the range shifter. A water phantom (Digiphant,IBA Dosimetry, Schwarzenbruck, Germany), which combines a twodimensional ionization chamber array (MatriXX PT ® , IBA Dosimetry, Schwarzenbruck, Germany) dedicated to address the high-dose rates in PBS, in a waterproof housing that can be scanned in a water phantom, was used to measure the two-dimensional (2D) dose distributions in selected depth perpendicular to the beam incident direction. 36 Measurements without the range shifter were obtained with the water phantom surface at isocenter and with an air gap of 150 mm to the range shifter.
Lastly, absolute output calculated by MC was validated using Before importing patient DICOM files into TOPAS, structures such as the couch, anterior bolus, head bolus, and artifacts, were replaced with overridden CT values in a manner identical to that of our current clinical planning process. A conversion from HU to human tissues (including elemental composition, weights, and density) was also implemented using the method described by Schneider et al, 37 with a correction factor to normalize the density in the MC system to mimic the HU-vs-relative stopping power table in our commercial planning system. 39 Heavy charged secondary particles are fully simulated by scaling proton stopping powers using the particle charge and mass. The change of spot size, σ, for the IBA dedicated PBS nozzle for 115 MeV and 210 MeV is shown in Fig. 2(a) . We can observe that the σ in the x direction first focuses (decreases) then subsequently defocuses (increases) from upstream to downstream, while continuously defocusing in y direction. This is due to the integrated focusing effect of the two quadruples as well as less air scattering in the dedicated nozzle compared to universal nozzle. The spot sigma generally decreases with energy, and the shape is more elliptical for lower energy [ Fig. 2(b) ]. From 210 to 225 MeV, however, the spot sigma unexpectedly increases. We speculate that this phenomenon is due to better beam focusing at 210 MeV than at 225 MeV. Figure 2(c) shows the dependence of σ θ on energy, which decreases from 6 mrad at 100 MeV to~3 mrad at 210 MeV. This is comparable with the values reported by Grevillot et al. 28 The number of protons per MU increases from~9E7 at 100 MeV to~1.5E8 at 225 MeV, and is proportional to electronic proton stopping power within 1%. 
3.B | Validation of spot size
3.C | Validation of the halo
The primary transverse dose spread of each single spot is due to MCS interactions within the medium and propagation through air, as 
3.D | Validation of dose distribution in water
The measured and simulated depth doses along the central axis for three different SOBPs, both without and with a range shifter, are shown in Fig. 9 . Simulations agree well with measured data, with a maximum dose difference of less than 2.2% and a clinical range agreement within 0.6 mm. Tables 1 and 2 Table 3 . It can be observed that the gamma pass rate is improved significantly, from 66% to over 93% for TOPAS over the axial plane, while the sagittal and coronal plane agreements were improved from below 85%, the passing threshold, to over 98%. The output measurement results
showed an overestimation of dose to the center of the target by 4%
for TPS while TOPAS had a good agreement within 1% of measurement. Although TOPAS has better general agreement with measurement than the TPS, we can find TOPAS overestimates the dose in we think the profile differences between TOPAS and measurements are not significant. The range uncertainty in TOPAS is likely caused by the uncertainty in CT and material conversion. The measurements add additional uncertainty due to film dosimetry and experimental setup. Figure 11 shows MC calculations for a representative plan of a patient with primary liver cancer originally planned using the commercial TPS. The plan consisted of two anterior oblique (10°and 280°) fields. The TOPAS plan is shown in one representative axial plane in Fig. 11(a) with the iCTV and liver (total liver minus GTV) DVHs in Fig. 11(b) . The coverage (D95, the maximum dose that covers 95% of the target volume) and the overdose (D02, the maximum dose that covers 2% of the target volume) indices are within 1% 
3.F | Application examples
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